Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

Project Financing

29 Jul 2008 11:07

RNS Number : 1000A
Ovoca Gold PLC
29 July 2008
Ā 



Ovoca Gold PLC

29Ā July 2008

Ā 

Ovoca Gold plc ("Ovoca" of the "Company")

Project Financing

OvocaĀ (London AIM (OVG.L), Frankfurt (OVX.GR) and Dublin IEX (OVX.IR))Ā is pleased to announce that it has signed a non-binding term sheet with a major RussianĀ bankingĀ institution for a USD 92.7 million project loan facility to cover capital costs for the Goltsovoye silver mine project. The contingency applied to the pre production capital costs estimate by Scott Wilson Mining has been increased by 15% inĀ the light of recent inflation. Proceeds of the facility will be used to financeĀ construction and commissioningĀ of the Goltsovoye silver mine.Ā TheĀ bank due diligence procedures isĀ expected take 10 to 12 weeks to finalizeĀ Ā 

Ā 

According to the Bankable Feasibility Study (BFS) carried out by Scott Wilson Mining, annual average mine productionĀ will be 260,000 tonnes of ore,Ā andĀ 5.8 million ounces of silver, during aĀ six year mine lifeĀ based on the reserves inĀ Ore Zone I.Ā In early 2007Ā Wardell ArmstrongĀ completed a JORC silver resource estimate ofĀ 69 million ouncesĀ in Ore Zones I and II. The Russian Government Commission for Natural Resources (GKZ)Ā later approved a resource ofĀ 81.33 million ounces of silverĀ inĀ theseĀ Zones.Ā The mine life is expected to be considerably longer than the 6 years.Ā 

In addition to Goltsovoye,Ā Ā Ovoca has a number of other projects located in the Kola Peninsula at advanced feasibility stages, such as Pellapahk which is a molybdenum-copper project with a potentially world class molybdenum resource.

Leonid Skoptsov, the Ovoca CEO, comments:

"I am glad that despite the turbulent financial and adverse credit markets, the Goltosovoye project has continued to attract significant interest from a number of banks. The signing of a term sheet with a major Russian bank is yet a further indication of the strength of both the project and the Russian financial system."

The above information has been reviewed and verified by Roger Turner, a Director ofĀ Ovoca, for the purposes of Mining, Oil and Gas Companies issued by TheĀ London Stock ExchangeĀ in March 2006. Mr. Turner with 41 years mining engineering, management and consultingĀ experience,Ā graduated as a mining engineer from the Camborne School of Mines and has an MSc degree in Economic Geology from Leicester University. He is a member in good standing of the Institute of Materials, Mining and Metallurgy and is a UK Chartered Engineer.

For further information contact

Ovoca Gold plc

Mr. Danesh Varma CFO

+44Ā 8452 606 034

danesh.varma@ovocagold.comĀ 

Mr. Leonid Skoptsov CEO

+7 495 648 26 46

leonid.skoptsov@ovocagold.comĀ 

Davy

John FrainĀ / Fergal Meegan

+353 1 679 6363

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
MSCUKRRRWNRBUAR
Date   Source Headline
29th Jul 20227:00 amRNSCompletion of Enrollment in Phase II Study
30th Jun 20227:00 amRNSAnnual Financial Report
7th Mar 20229:00 amRNSStatement re Russian Business Operations
23rd Feb 20224:41 pmRNSSecond Price Monitoring Extn
23rd Feb 20224:36 pmRNSPrice Monitoring Extension
22nd Feb 20223:30 pmRNSRussian Marketing Authorisation for Orenetide
31st Jan 20227:00 amRNSBoard Changes and Update
30th Dec 20217:00 amRNSDirectorate Change
4th Nov 20213:53 pmRNSHolding(s) in Company
4th Nov 20213:50 pmRNSDirector/PDMR Shareholding
4th Nov 20213:46 pmRNSBoard Change
14th Sep 20217:00 amRNSInterim Results
29th Jul 20215:00 pmRNSResult of AGM
24th Jun 20217:00 amRNSAnnual Report and Notice of AGM
10th Mar 20217:00 amRNSMigration of Participating Securities
16th Feb 20212:00 pmRNSResult of EGM
29th Jan 20217:00 amRNSFirst Patient Enrolled in Phase II Study - BP-101
25th Jan 20213:30 pmRNSNotice of EGM
5th Jan 20217:00 amRNSRe-Filing of Marketing Authorisation Application
17th Dec 20202:45 pmRNSResult of AGM
27th Nov 20203:08 pmRNSNotice of AGM
9th Oct 20207:00 amRNSAppointment of Chief Business Officer
2nd Oct 202011:06 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
2nd Oct 20207:00 amRNSUpdate re Russian Marketing Authorisation
28th Sep 20207:00 amRNSDeath of a Director
21st Sep 20207:00 amRNSInterim Results
14th Aug 202011:05 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
26th Jun 20207:00 amRNSAnnual Report
14th Apr 20202:05 pmRNSSecond Price Monitoring Extn
14th Apr 20202:00 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSAcquisition of Remaining Minority Interest in IVIX
7th Nov 201912:45 pmRNSAttendance at Bio-Europe Conference
16th Sep 20197:00 amRNSInterim Results
12th Sep 20197:00 amRNSFiling of Marketing Authorisation Application
28th Aug 20197:00 amRNSDirectorate Change
8th Aug 20194:14 pmRNSResult of AGM
8th Aug 20199:05 amRNSSecond Price Monitoring Extn
8th Aug 20199:00 amRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSAGM Statement
26th Jul 20197:00 amRNSDirectorate Change
25th Jul 20194:41 pmRNSSecond Price Monitoring Extn
25th Jul 20194:35 pmRNSPrice Monitoring Extension
28th Jun 20197:00 amRNSAnnual Report and Notice of AGM
23rd Apr 20197:00 amRNSUS and EU Clinical Development Plans
29th Mar 20197:00 amRNSDirector/PDMR Shareholding
27th Mar 20197:00 amRNSOperational Update & Additional Investment in IVIX

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.